Clinical utility of telavancin for treatment of hospital-acquired pneumonia: focus on non-ventilator-associated pneumonia

BACKGROUND: Hospital-acquired pneumonia (HAP) is the most common health care-associated infection contributing to death. Studies have indicated that there may be differences in the causative pathogens and outcomes of ventilator-associated pneumonia (VAP) and non-ventilator-associated pneumonia (NV-H...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubinstein, Ethan, Stryjewski, Martin E, Barriere, Steven L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035308/
https://www.ncbi.nlm.nih.gov/pubmed/24876786
http://dx.doi.org/10.2147/IDR.S25930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4035308/
https://www.ncbi.nlm.nih.gov/pubmed/24876786
http://dx.doi.org/10.2147/IDR.S25930

Ejemplares similares